Kubota Pharmaceutical HoldingsKubota Pharmaceutical Holdings Co., Ltd.4596東証グロース医薬品FY ending Dec 2023, consolidated, IFRS
Revenue changed +383.2% from the prior year.
Net margin × asset turnover = ROA; ROA × financial leverage = ROE
| Period | Net margin | Asset turnover | ROA | Financial leverage | ROE |
|---|---|---|---|---|---|
| 2016 | — | —× | -22.8% | —× | — |
| 2020 | — | —× | -36.4% | —× | — |
| 2022 | — | —× | -45.6% | —× | — |
| 2023 | — | —× | -40.1% | —× | — |
Financial leverage can raise ROE; a higher value alone does not describe a company's overall condition.
Annual trends in tangible-asset ratios and goodwill balance.
Ratios are derived from reported values. Goodwill is shown only when separately reported; it is not inferred from combined intangible assets. Definition
Track R&D investment and how long operating capital remains tied up before sales turn into cash.
R&D is shown only for years with machine-readable disclosure. Days are estimates using year-end receivables, inventory and payables divided by annual revenue or cost of sales; financial companies are excluded.
| Item | FY ending Dec 2016 | FY ending Dec 2020 | FY ending Dec 2022 | FY ending Dec 2023 |
|---|---|---|---|---|
| Revenue | 846 | 38 | 8 | 40 |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| SG&A | — | — | — | — |
| Operating income | — | -2,484 | — | — |
| Pretax income | -3,911 | -2,437 | -2,016 | -1,490 |
| Income tax | — | — | — | — |
| Net income attributable to owners | -3,911 | -2,437 | -2,016 | -1,490 |
| Operating margin | — | -6574.0% | — | — |
Year-end figures from filings. Unreported items are omitted. Interest-bearing debt excludes lease liabilities.
| Item | FY ending Dec 2016 | FY ending Dec 2020 | FY ending Dec 2022 | FY ending Dec 2023 |
|---|---|---|---|---|
| Cash and equivalents | ¥1.04B | ¥2.53B | ¥4.05B | ¥2.77B |
| Total assets | ¥17.2B | ¥6.69B | ¥4.42B | ¥3.02B |
| Net assets | — | ¥5.99B | — | ¥2.65B |
| Share capital | — | ¥1.15B | — | — |
| Property, plant and equipment | — | ¥220.2M | — | — |
| Current assets | — | ¥6.42B | — | — |
| Total liabilities | — | ¥698.9M | — | — |
| Equity attributable to owners of parent | — | ¥5.99B | — | — |
| Retained earnings | — | -¥19.5B | — | — |
EDINET (FSA Japan)
有価証券報告書－第11期(2025/01/01－2025/12/31)
EDINET (FSA Japan)
有価証券報告書－第10期(2024/01/01－2024/12/31)
EDINET (FSA Japan)
有価証券報告書－第8期(2022/01/01－2022/12/31)
EDINET (FSA Japan)
有価証券報告書－第7期(令和3年1月1日－令和3年12月31日)
EDINET (FSA Japan)
有価証券報告書－第6期(令和2年1月1日－令和2年12月31日)
Extracted from XBRL: 10 / Derived from other figures: 1
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.